Sustained Virologic Response
Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C
8
Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin
7
Liver-related morbidity and mortality in patients with chronic hepatitis C and cirrhosis with and without sustained virologic response
16
High sustained virologic response rates of sofosbuvir based regimens in Chinese patients with HCV genotype 3a infection in a real world setting
9
A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients
9
Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance
5
Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co infected patients, Cohere in Eurocoord
10
<p>Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study</p>
7
Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study
6
Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits
19
The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease
8
Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C
18
Top topics in HCV research arena
5
Very rapid virologic response and early HCV response kinetics, as quick measures to compare efficacy and guide a personalized response-guided therapy
9
FTOrs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients
11
Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents
17
Profile of alisporivir and its potential in the treatment of hepatitis C
11
Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review
9
Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
9
PubMedCentral-PMC4996139.pdf
8